mcknights
ajmc
nonprofitquarterly
oregonlive
time.news
dailynurse
pubmed
apnews
In patients with large B-cell lymphoma (LBCL), treatment with axicabtagene ciloleucel (axi-cel;Yescarta; Kite Pharma, Gilead) was associated with a favorable overall survival (OS), progression free survival (PFS), and safety profile regardless […]
Axi-Cel Shows Favorable Outcomes in Large B-Cell Lymphoma Regardless of Race, Ethnicity Read More »
…according to the National Institute of Allergy and Infectious Diseases. Black and Hispanic children who live in these environments are at particularly high risk for asthma and are prone to
NIAID trial to test asthma drug in disadvantaged urban children Read More »
 For Immediate Release June 2, 2022  Contact: Mike Inacay or Manu Tupper (202) 224-3123  CHAIRMAN SCHATZ LEADS COMMITTEE FIELD HEARING IN HILO ON FEDERAL RESOURCES FOR THE
Country United States of AmericaUS Virgin IslandsUnited States Minor Outlying IslandsCanadaMexico, United Mexican StatesBahamas, Commonwealth of theCuba, Republic ofDominican RepublicHaiti, Republic ofJamaicaAfghanistanAlbania, People’s Socialist Republic ofAlgeria, People’s Democratic Republic ofAmerican
Latina activists and entrepreneurs Jess Morales Rocketto and Stephanie Valencia have raised $80 million to launch a new Spanish media company, the Latino Media Network. Why it matters: It’s one
New Latino Media Startup Launches with Historic $80 Million in Revenue Read More »
Little data exist on the effectiveness of dupilumab in Black and Hispanic children, even though severe asthma disproportionately affects these populations. The National Institutes of Health (NIH) said this week
NIH Launches Phase 2 Trial of Biologic in Urban Youth With Type 2 Allergic Asthma Read More »
mcknights
dailynurse
mcknights
ajmc
nonprofitquarterly
oregonlive
time.news
dailynurse
pubmed
apnews
statnews
usatoday
pubmed
